002332 仙琚制药
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)5.86610.01614.56313.34913.660
总资产报酬率 ROA (%)4.8758.20211.1309.1307.969
投入资产回报率 ROIC (%)5.4899.22212.87910.7849.556

边际利润分析
销售毛利率 (%)54.84352.87658.15558.04955.637
营业利润率 (%)19.14815.67820.06017.41114.861
息税前利润/营业总收入 (%)17.94015.02119.29716.75217.588
净利润/营业总收入 (%)16.26313.63217.06514.25813.163

收益指标分析
经营活动净收益/利润总额(%)100.10098.73184.42194.16590.762
价值变动净收益/利润总额(%)4.396-1.3995.6614.0040.986
营业外收支净额/利润总额(%)-0.549-0.745-0.769-3.9443.865

偿债能力分析
流动比率 (X)3.2813.2483.5442.5722.316
速动比率 (X)2.3142.3662.6251.9171.867
资产负债率 (%)15.82816.62818.26326.4300.330
带息债务/全部投入资本 (%)3.9356.5256.97113.84722.112
股东权益/带息债务 (%)2,412.1051,413.7521,318.096612.661347.349
股东权益/负债合计 (%)527.242497.607443.491271.852197.037
利息保障倍数 (X)-16.254-27.753-31.64211,117.8498.259

营运能力分析
应收账款周转天数 (天)49.42748.24945.98951.74662.703
存货周转天数 (天)175.585167.981176.901161.136141.089